共 50 条
- [21] Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIVJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (05) : E234 - E236Gay, Cynthia L.Bosch, Ronald J.McKahnn, AshleyMoseley, Kendall F.Wimbish, Chanelle L.Hendrickx, Steven M.Messer, MichaelFurlong, MaureenCampbell, Danielle M.Jennings, CherylBenson, ConstanceOverton, Edgar T.Macatangay, Bernard J. C.Kuritzkes, Daniel R.Miller, ElizabethTressler, RandallEron, Joseph J.Hardy, William David
- [22] Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse EventsCANCERS, 2023, 15 (05)Les, InigoMartinez, MireiaPerez-Francisco, InesCabero, MariaTeijeira, LuciaArrazubi, VirginiaTorrego, NuriaCampillo-Calatayud, AnaElejalde, InakiKochan, GrazynaEscors, David
- [23] Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S598 - S599Toi, Y.Sugawara, S.Aso, M.Tsurumi, K.Ono, K.Sugisaka, J.Shimizu, H.Ono, H.Domeki, Y.Aiba, T.Kawana, S.Saito, R.Terayama, K.Kawashima, Y.Nakamura, A.Yamanda, S.Kimura, Y.Honda, Y.
- [24] Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected MelanomaJAMA ONCOLOGY, 2021, 7 (05) : 744 - 748Patrinely, J. Randall, Jr.Johnson, RebeccaLawless, Aleigha R.Bhave, PrachiSawyers, AmeliaDimitrova, MayaYeoh, Hui LingPalmeri, MarisaYe, FeiFan, RunDavis, Elizabeth J.Rapisuwon, SutheeLong, Georgina V.Haydon, AndrewOsman, ImanMehnert, Janice M.Carlino, Matteo S.Sullivan, Ryan J.Menzies, Alexander M.Johnson, Douglas B.
- [25] Delayed immune-related adverse events (irAEs) on anti-PD1-based therapyANNALS OF ONCOLOGY, 2020, 31 : S761 - S762Owen, C. N.Bai, X.Quah, T.Lo, S.Callaghan, S.Martinez-Vila, C.Bhave, P.Reijers, I.Gerard, C. L.Aspelagh, S.Xu, W.Welsh, S. J.Sandhu, S.Mangana, J.McQuade, J. L.Ascierto, P. A.Zimmer, L.Johnson, D. B.Lebbe, C.Menzies, A. M.
- [26] Sarcopenia predicts immune-related adverse events due to anti-PD-1/PD-L1 therapy in patients with advanced lung cancerFRONTIERS IN ONCOLOGY, 2024, 14Xue, DinglongLi, NingYang, JiaxinMen, KaiyaLi, LijunJiang, HaoZhao, XuZhang, Shuai
- [27] Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyCANCER TREATMENT REVIEWS, 2016, 45 : 7 - 18Eigentler, Thomas K.Hassel, Jessica C.Berking, CarolaAberle, JensBachmann, OliverGruenwald, ViktorKaehler, Katharina C.Loquai, CarmenReinmuth, NielsSteins, MartinZimmer, LisaSendl, AnnaGutzmer, Ralf
- [28] Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World StudyFRONTIERS IN IMMUNOLOGY, 2021, 12Liu, WenhuiMa, FangSun, BaoLiu, YipingTang, HaonengLuo, JianquanChen, HuiqingLuo, Zhiying
- [29] Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational studyLANCET HAEMATOLOGY, 2019, 6 (01): : E48 - E57Delaney, NicolasMichot, Jean-MarieComont, ThibaultKramkimel, NoraLazarovici, JulienDupont, RomainChampiat, StephaneChahine, ClaudeRobert, CarolineHerbaux, CharlesBesse, BenjaminGuillemin, AudeMateus, ChristinePautier, PatriciaSaiag, PurippeMadonna, EnmauelaMaerevoet, MarieBout, Jeao-ChristopheLeduc, CharlotteBiscay, PascalQuere, GillesNardin, CharleeEbbo, MikaelAlbiges, LaurenceMarret, GregoireLevrat, VirginieDujon, CecileVargaftig, JacquesLaghouati, SalimCroisille, LoureVoisin, Anne-LaureGodeau, BertrandMassard, ChristopheRibrag, VincentMarabelle, AurellenMichel, MarcLambotte, Olivier
- [30] Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysisBMJ-BRITISH MEDICAL JOURNAL, 2018, 360Baxi, ShrujalYang, AnnieGennarelli, Renee L.Khan, NilouferWang, ZiweiBoyce, LindsayKorenstein, Deborah